Related references
Note: Only part of the references are listed.Cost evaluation of antibody production processes in different operation modes
Stephan Klutz et al.
CHEMICAL ENGINEERING SCIENCE (2016)
From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy
Andreas H. Laustsen et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Biotechnological Trends in Spider and Scorpion Antivenom Development
Andreas Hougaard Laustsen et al.
TOXINS (2016)
High-throughput immuno-profiling of mamba (Dendroaspis) venom toxin epitopes using high-density peptide microarrays
Mikael Engmark et al.
SCIENTIFIC REPORTS (2016)
Oligoclonal antibodies to target the ErbB family
Jimson W. D'Souza et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Developing the biofacility of the future based on continuous processing and single-use technology
Stephan Klutz et al.
JOURNAL OF BIOTECHNOLOGY (2015)
Phage display as a novel promising antivenom therapy: A review
Eduardo Crosara Roncolato et al.
TOXICON (2015)
Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score
Andreas H. Laustsen et al.
TOXICON (2015)
Antivenomic Characterization of Two Antivenoms Against the Venom of the Taipan, Oxyuranus Scutellatus, from Papua New Guinea and Australia
Maria Herrera et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation
Nikolaus Hammerschmidt et al.
BIOTECHNOLOGY JOURNAL (2014)
Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometry
Natalie J. Thompson et al.
MABS (2014)
Biopharmaceutical benchmarks 2014
Gary Walsh
NATURE BIOTECHNOLOGY (2014)
Recombinant antibody mixtures: Production strategies and cost considerations
Soren K. Rasmussen et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Consequences of Neglect: Analysis of the Sub-Saharan African Snake Antivenom Market and the Global Context
Nicholas I. Brown
PLOS NEGLECTED TROPICAL DISEASES (2012)
Short-Term Outcomes After Fab Antivenom Therapy for Severe Crotaline Snakebite
Eric J. Lavonas et al.
ANNALS OF EMERGENCY MEDICINE (2011)
Ending the drought: New strategies for improving the flow of affordable, effective antivenoms in Asia and Africa
David J. Williams et al.
JOURNAL OF PROTEOMICS (2011)
Preclinical Evaluation of Caprylic Acid-Fractionated IgG Antivenom for the Treatment of Taipan (Oxyuranus scutellatus) Envenoming in Papua New Guinea
Mariangela Vargas et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Generation of Stable Cell Clones Expressing Mixtures of Human Antibodies
John de Kruif et al.
BIOTECHNOLOGY AND BIOENGINEERING (2010)
Clinical Ramifications of the MHC Family Fc Receptor FcRn
Derry C. Roopenian et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Recovery and purification process development for monoclonal antibody production
Hui F. Liu et al.
MABS (2010)
Therapeutic antibodies for autoimmunity and inflammation
Andrew C. Chan et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Industrialization of mAb production technology The bioprocessing industry at a crossroads
Brian Kelley
MABS (2009)
The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and Deaths
Anuradhani Kasturiratne et al.
PLOS MEDICINE (2008)
Process economics of industrial monoclonal antibody manufacture
Suzanne S. Farid
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Production of target-specific recombinant human polyclonal antibodies in mammalian cells
Finn C. Wiberg et al.
BIOTECHNOLOGY AND BIOENGINEERING (2006)
Confronting the neglected problem of snake bite envenoming: The need for a global partnership
Jose Maria Gutierrez et al.
PLOS MEDICINE (2006)
Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography
R Raweerith et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation
JM Gutierrez et al.
CLINICAL PHARMACOKINETICS (2003)
Therapeutic antibody expression technology
HE Chadd et al.
CURRENT OPINION IN BIOTECHNOLOGY (2001)
Share Paper
